Biotechnology companies apply biological science to develop products, services and technologies that address challenges in healthcare, agriculture, industry and environmental sustainability.
This category includes companies working on:
Browse 463 UK biotechnology companies below.
Engineered hybrid interferon therapeutics for viral and immune-mediated disease
ILC Therapeutics is a pre-clinical biotechnology company developing hybrid interferons, an engineered cytokine drug class combining favourable attributes of multiple naturally…
Allogeneic neutrophil cell therapy platform for solid tumours
LIfT BioSciences is a biotechnology company developing a first-in-class allogeneic neutrophil immunotherapy for the treatment of solid tumours. Its platform produces…
AI platform designing vaccines against current and future pathogens
Baseimmune is a biotechnology company developing a deep learning platform for computational vaccine antigen design. The platform integrates genomic, epidemiological,…
Precision medicine platform matching cancer patients to optimal therapies
Pathway Bio is a precision oncology company developing a functional platform to predict treatment response in individual cancer patients. The platform combines multiomic tumour…
Genomic risk prediction platform for preventive healthcare and drug discovery
Genomics is a data science company that uses large-scale human genetic data to power precision healthcare and drug discovery. Its proprietary platform links millions of genetic…
Engineered iPSC-derived exosomes for tissue-targeted drug delivery
Excellio Labs is a biotech developing engineered exosome platforms for targeted drug delivery. The technology exploits the inherent tissue-specificity of iPSC-derived…
Clinical-stage rare disease biotech acquiring deprioritised pharma assets
Mereo BioPharma is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases. Founded in 2015, its business model centres on acquiring…
Novel mode-of-action herbicide discovery platform
Moa Technology discovers synthetic and biological herbicides with novel modes of action to address herbicide resistance. Its high-throughput platform uses miniaturised living…
Small molecule protein degraders targeting oncology and CNS disease
Kesmalea Therapeutics is a biotechnology company developing oral small molecule therapeutics that modulate protein homeostasis through targeted protein degradation and…
Hydrogel capsule platform for weight loss and oral drug delivery
Oxford Medical Products is developing a gastroretentive hydrogel platform with two applications. The technology is a swallowable dual-polymer capsule that expands in the stomach…
Small molecule remyelination therapeutics for neurological diseases
Pheno Therapeutics is a Scottish clinical-stage biotechnology company developing small molecule therapeutics that promote remyelination by boosting the function of…
Precision oncology biotech targeting novel DNA damage response pathways
Nodus Oncology is a preclinical-stage biotechnology company developing small molecule inhibitors against novel DNA damage response targets for molecularly defined cancer patient…